Scott J. Rodig, MD, PhD is an internationally recognized hematopathologist, physician‑scientist, and academic leader has joined the BIDMC Department of Pathology as Vice Chair of Hematopathology, and new position for the department. A Professor of Pathology at Harvard Medical School and an attending pathologist at Brigham and Women’s Hospital and Dana‑Farber Cancer Institute, Dr. Rodig brings more than two decades of clinical, research, and leadership experience at the forefront of hematologic malignancies.

He has authored over 350 peer‑reviewed publications, ranks among the top 1% of most‑cited researchers in clinical medicine, and has played a pivotal role in discoveries and diagnostic innovations that have shaped modern lymphoma care. In his new role, Dr. Rodig will lead and strengthen collaboration between Dana‑Farber’s Hematologic Malignancies programs and BIDMC Pathology, advancing integrated clinical care, translational research, and education.